Gadolinium-dependent contrast brokers (GBCAs) are widely Employed in magnetic resonance imaging (MRI) to reinforce the visibility of blood vessels, tumors, inflammation, and various inside structures. Though frequently viewed as Risk-free, considerations about GBCA toxicity have emerged in the last 20 years—particularly in clients with impaired k